MYC and cancer: The capability of BRD4 to influence the transcription of key oncogenes, like MYC, through its association with super-enhancers—large clusters of transcriptional enhancers critical for maintaining cell identity and disease progression, notably in cancer underscores its therapeutic relevance [1].